Artwork

内容由Jon Chee提供。所有播客内容(包括剧集、图形和播客描述)均由 Jon Chee 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future Plans

22:26
 
分享
 

Manage episode 423369312 series 3461709
内容由Jon Chee提供。所有播客内容(包括剧集、图形和播客描述)均由 Jon Chee 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.


Part 4 of 4.

My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complications.

In addition to his work at Ochre, Quin is also a highly accomplished academic with a medical degree from Witwatersrand University and doctoral degrees from Cambridge and Oxford in computational biology, mathematics, and statistical genomics.

Along with his academic accomplishments, Quin also co-founded SimuGen and has worked at the University College London, the Mayo Clinic, and Novo Nordisk before he went on to co-found Ochre Bio. Quin's diverse experiences offer a wealth of insights that everyone can draw inspiration from.

Join us this week and hear about Quin’s:

  • Unique journey through Y Combinator and its impact
  • Thoughts about empathy’s role in organizational and team dynamics
  • Strategies for adapting as an entrepreneur in a shifting biotech landscape
  • Experience expanding Ochre Bio globally and the challenges of scaling
  • Fundraising journey and his unconventional tips for aspiring entrepreneurs

Please enjoy my conversation with Quin Wills.
Find Our Guest, Quin Wills, at these links:

Find Our Host, Jon Chee, at these links:
00:28 Intro
01:46 Applying to and joining Y Combinator
03:19 Building a full stack solution for Ochre Bio and generating critical data
05:04 The impact of COVID-19, expanding globally to Taiwan and the US
08:48 Day-to-day operations and scientific structure of Ochre Bio
09:42 Investing in chemistry, establishing XLAB and its role in innovation and decision-making
11:42 Balancing innovation and value-driven projects, defining metrics of success
12:38 Quin’s fundraising journey, insights, and philosophy
13:49 The importance of focus and ending unproductive projects quickly
16:11 Ochre Bio’s evolution and future plans
17:19 Quin’s shoutouts and advice to his 21-year-old self
20:03 Outro

Social & Website
Enriched Notes:
Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

56集单集

Artwork
icon分享
 
Manage episode 423369312 series 3461709
内容由Jon Chee提供。所有播客内容(包括剧集、图形和播客描述)均由 Jon Chee 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.


Part 4 of 4.

My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complications.

In addition to his work at Ochre, Quin is also a highly accomplished academic with a medical degree from Witwatersrand University and doctoral degrees from Cambridge and Oxford in computational biology, mathematics, and statistical genomics.

Along with his academic accomplishments, Quin also co-founded SimuGen and has worked at the University College London, the Mayo Clinic, and Novo Nordisk before he went on to co-found Ochre Bio. Quin's diverse experiences offer a wealth of insights that everyone can draw inspiration from.

Join us this week and hear about Quin’s:

  • Unique journey through Y Combinator and its impact
  • Thoughts about empathy’s role in organizational and team dynamics
  • Strategies for adapting as an entrepreneur in a shifting biotech landscape
  • Experience expanding Ochre Bio globally and the challenges of scaling
  • Fundraising journey and his unconventional tips for aspiring entrepreneurs

Please enjoy my conversation with Quin Wills.
Find Our Guest, Quin Wills, at these links:

Find Our Host, Jon Chee, at these links:
00:28 Intro
01:46 Applying to and joining Y Combinator
03:19 Building a full stack solution for Ochre Bio and generating critical data
05:04 The impact of COVID-19, expanding globally to Taiwan and the US
08:48 Day-to-day operations and scientific structure of Ochre Bio
09:42 Investing in chemistry, establishing XLAB and its role in innovation and decision-making
11:42 Balancing innovation and value-driven projects, defining metrics of success
12:38 Quin’s fundraising journey, insights, and philosophy
13:49 The importance of focus and ending unproductive projects quickly
16:11 Ochre Bio’s evolution and future plans
17:19 Quin’s shoutouts and advice to his 21-year-old self
20:03 Outro

Social & Website
Enriched Notes:
Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

56集单集

Toate episoadele

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南